New Multi-Hospital Partner Joins OneMedNet’s Expansive Real World Data Network

2 years ago

~ Partnership Reinforces RWD Leadership for Life Science Innovation ~MINNEAPOLIS, MN / ACCESSWIRE / January 11, 2024 / OneMedNet Corporation,…

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

2 years ago

WORCESTER, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical…

Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study

2 years ago

The 7-peptide formulation of ELI-002 is designed to stimulate an immune response against seven KRAS mutations that drive 25% of…

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

2 years ago

Mr. McCarrey brings a strong track record of success and deep experience in regenerative medicine marketsPOMPANO BEACH, Fla., Jan. 11,…

Nexalin Technology Unveils Next-Generation HALO™ Clarity

2 years ago

HALO™ Clarity headset Photo: HALO™ Clarity headset A new neurostimulation device to combat the growing global mental health epidemic Designed…

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

2 years ago

WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology…

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

2 years ago

BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

2 years ago

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company…

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

2 years ago

DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)…

TransCode Therapeutics Announces 1-for-40 Reverse Stock Split

2 years ago

BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™…